Express Pharma

WuXi Biologics and GSK enter into licence agreement on multiple T Cell Engagers

WuXi Biologics will receive a $40 million upfront payment and up to $1.46 billion in additional payments for research, development, regulatory and commercial milestones across four TCE antibodies

3 424